Waldron Private Wealth LLC Neu Base Therapeutics, Inc. Transaction History

Waldron Private Wealth LLC

  • $2.4 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Aug 29, 2024
BUY
$0.17 - $0.39 $13,535 - $31,051
79,620 New
79,620 $14,000
Q1 2022

May 04, 2022
BUY
$1.26 - $2.95 $75,010 - $175,619
59,532 Added 296.36%
79,620 $149,000
Q2 2021

Aug 06, 2021
BUY
$4.63 - $7.34 $93,007 - $147,445
20,088 New
20,088 $96,000

About NeuBase Therapeutics, Inc.

NBSE Quotes by TradingView
  • Ticker NBSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,258,700
  • Description
  • NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...
More about NBSE
Track This Portfolio

Track Waldron Private Wealth LLC Portfolio

Follow Waldron Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waldron Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waldron Private Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email